✦ LIBER ✦

Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir

✍ Scribed by Hulskotte, E. G. J.; Feng, H.-P.; Xuan, F.; van Zutven, M. G. J. A.; Treitel, M. A.; Hughes, E. A.; O'Mara, E.; Youngberg, S. P.; Wagner, J. A.; Butterton, J. R.

Book ID: 126725307
Publisher: University of Chicago Press
Year: 2012
Tongue: English
Weight: 195 KB
Volume: 56
Category: Article
ISSN: 1058-4838
DOI: 10.1093/cid/cis968

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic interaction between the

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

✍ Hulskotte, Ellen; Gupta, Samir; Xuan, Fengjuan; van Zutven, Marga; O'Mara, Edwar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Pharmacokinetic and pharmacodynamic inte

Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone

✍ W. H. Lin; H. Feng; C. R. Shadle; T. O’reilly; J. A. Wagner; J. R. Butterton 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 267 KB

Pharmacokinetic Evaluation of the Intera

Pharmacokinetic Evaluation of the Interaction between Hepatitis C Virus Protease Inhibitor Boceprevir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Pravastatin

✍ Hulskotte, E. G. J.; Feng, H.- P.; Xuan, F.; Gupta, S.; van Zutven, M. G. J. A.; 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 484 KB

Clinical Assessment of Potential Drug In

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

✍ Sabo, J. P.; Kort, J.; Ballow, C.; Haschke, M.; Battegay, M.; Fuhr, R.; Girlich, 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 509 KB

Evaluation of pharmacokinetic interactio

Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers

✍ G. Peytavin; C. Gautran; C. Otoul; A. C. Cremieux; B. Moulaert; F. Delatour; M. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 246 KB

Management of drug-to-drug interactions

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi